Cargando…
The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells
3-bromopyruvate (3-BP) is a small molecule with anticancer and antimicrobial activities. 3-BP is taken up selectively by cancer cells’ mono-carboxylate transporters (MCTs), which are highly overexpressed by many cancers. When 3-BP enters cancer cells it inactivates several glycolytic and mitochondri...
Autores principales: | Cal, Magdalena, Matyjaszczyk, Irwin, Litwin, Ireneusz, Augustyniak, Daria, Ogórek, Rafał, Ko, Young, Ułaszewski, Stanisław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290944/ https://www.ncbi.nlm.nih.gov/pubmed/32397119 http://dx.doi.org/10.3390/cells9051161 |
Ejemplares similares
-
Mitochondrial Function Are Disturbed in the Presence of the Anticancer Drug, 3-Bromopyruvate
por: Cal, Magdalena, et al.
Publicado: (2021) -
Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma
por: Niedźwiecka, Katarzyna, et al.
Publicado: (2016) -
Screening the yeast genome for energetic metabolism pathways involved in a phenotypic response to the anti-cancer agent 3-bromopyruvate
por: Lis, Paweł, et al.
Publicado: (2016) -
Transport of 3-bromopyruvate across the human erythrocyte membrane
por: Sadowska-Bartosz, Izabela, et al.
Publicado: (2014) -
The HK2 Dependent “Warburg Effect” and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate
por: Lis, Paweł, et al.
Publicado: (2016)